CIRM Seeks Changes in NIH hESC Plans
The CIRM board of directors today approved recommendations for changes in proposed NIH rules for research involving human embryonic stem cells.
The action came on a 20-0 vote in a session during which directors were told that 7,000 responses to the rules had been received by the NIH. CIRM Chairman Robert Klein said the responses were running 7 to 1 again…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.